Dogwood Therapeutics, Net Income vs. Total Debt
| DWTX Stock | 2.40 0.20 7.69% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -5.3 M | Current Value -5.6 M | Quarterly Volatility 2.4 M |
For Dogwood Therapeutics, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Dogwood Therapeutics, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Dogwood Therapeutics, utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Dogwood Therapeutics,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Dogwood Therapeutics, over time as well as its relative position and ranking within its peers.
Dogwood |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dogwood Therapeutics,. If investors know Dogwood will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dogwood Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Dogwood Therapeutics, is measured differently than its book value, which is the value of Dogwood that is recorded on the company's balance sheet. Investors also form their own opinion of Dogwood Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Dogwood Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dogwood Therapeutics,'s market value can be influenced by many factors that don't directly affect Dogwood Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dogwood Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Dogwood Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dogwood Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Dogwood Therapeutics, Total Debt vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Dogwood Therapeutics,'s current stock value. Our valuation model uses many indicators to compare Dogwood Therapeutics, value to that of its competitors to determine the firm's financial worth. Dogwood Therapeutics, is rated below average in net income category among its peers. It is rated below average in total debt category among its peers . Dogwood Therapeutics, reported Net Loss of (5.3 Million) in 2023. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dogwood Therapeutics,'s earnings, one of the primary drivers of an investment's value.Dogwood Total Debt vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Dogwood Therapeutics, |
| = | (5.3 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Dogwood Therapeutics, |
| = | 358.55 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Dogwood Total Debt vs Competition
Dogwood Therapeutics, is rated below average in total debt category among its peers. Total debt of Biotechnology industry is currently estimated at about 107.32 Million. Dogwood Therapeutics, adds roughly 358,548 in total debt claiming only tiny portion of stocks in Biotechnology industry.
Dogwood Therapeutics, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Dogwood Therapeutics,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Dogwood Therapeutics, will eventually generate negative long term returns. The profitability progress is the general direction of Dogwood Therapeutics,'s change in net profit over the period of time. It can combine multiple indicators of Dogwood Therapeutics,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 150.9 K | 158.4 K | |
| Operating Income | -5.4 M | -5.7 M | |
| Net Loss | -5.3 M | -5.6 M | |
| Income Before Tax | -5.3 M | -5.6 M | |
| Total Other Income Expense Net | -292.5 K | -277.9 K | |
| Net Loss | -5.3 M | -5.6 M | |
| Interest Income | 150.9 K | 120.1 K |
Dogwood Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Dogwood Therapeutics,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Dogwood Therapeutics, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Dogwood Therapeutics,'s important profitability drivers and their relationship over time.
| Net Income vs Number Of Employees | ||
| Total Asset vs Total Debt | ||
| Net Income vs Retained Earnings | ||
| Working Capital vs Total Debt |
Use Dogwood Therapeutics, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dogwood Therapeutics, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dogwood Therapeutics, will appreciate offsetting losses from the drop in the long position's value.Dogwood Therapeutics, Pair Trading
Dogwood Therapeutics, Pair Trading Analysis
The ability to find closely correlated positions to Dogwood Therapeutics, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dogwood Therapeutics, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dogwood Therapeutics, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dogwood Therapeutics, to buy it.
The correlation of Dogwood Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dogwood Therapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dogwood Therapeutics, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dogwood Therapeutics, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Dogwood Therapeutics, position
In addition to having Dogwood Therapeutics, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Airlines Thematic Idea Now
Airlines
Domestic and international airlines and airline services. The Airlines theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Airlines Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Dogwood Stock Analysis
When running Dogwood Therapeutics,'s price analysis, check to measure Dogwood Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dogwood Therapeutics, is operating at the current time. Most of Dogwood Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Dogwood Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dogwood Therapeutics,'s price. Additionally, you may evaluate how the addition of Dogwood Therapeutics, to your portfolios can decrease your overall portfolio volatility.